Fig. 2
Kaplan–Meier analysis of survival according to XDH expression status in patients with different types of cancers using Kaplan–Meier plotter (A–N). A–D High XDH expression was correlated with worse overall survival (OS), progression-free survival (PFS), recurrence-free survival (RFS), and disease-specific survival (DSS) in hepatocellular carcinoma (HCC) cohorts (n = 364, n = 316, n = 370, n = 362). E–F Survival curves for OS and RFS in the bladder cancer cohort (n = 404, n = 187). G, H Survival curves for OS and RFS in the breast cancer cohort (n = 1402, n = 3951). I, J Survival curves for OS and RFS in the gastric cancer cohort (n = 875, n = 498). K, L Survival curves for OS and RFS in the lung cancer cohort (n = 1925, n = 344). M, N Survival curves for OS and RFS in the ovarian cancer cohort (n = 1656, n = 1435)